Tamar Rubinek

Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer

Rinath Jeselsohn, Roman Yelensky, Gilles Buchwalter et al. · Clinical Cancer Research · 2014 · 633 citations · Full text

Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer

Ido Wolf, S Levanon-Cohen, S Bose et al. · Oncogene · 2008 · 308 citations

Tumor Biology, Medicine, Receptor Tyrosine Kinase +9

Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin

Ingo Wolf, Yael Laitman, Tamar Rubinek et al. · Oncogene · 2009 · 52 citations

Oncology, Engineering, Cancer Risk +14

Mechanisms for Growth Factor-Induced Pituitary Tumor Transforming Gene-1 Expression in Pituitary Folliculostellate TtT/GF Cells

George Vlotides, Martha Cruz‐Soto, Tamar Rubinek et al. · Molecular Endocrinology · 2006 · 44 citations · Full text

Signal Transduction, Developmental Biology, Securin Protein +13

PTR-3173 (Somatoprim™), a novel somatostatin analog with affinity for somatostatin receptors 2, 4 and 5 is a potent inhibitor of human GH secretion

Ilan Shimon, Tamar Rubinek, Moshe Hadani et al. · Journal of Endocrinological Investigation · 2004 · 33 citations

Biochemistry, G Protein-coupled Receptor, Medicine +9